Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study

S. Cvitanovic, Z. Ivancevic (Split, Croatia)

Source: Annual Congress 2004 - Mesothelioma and malignant pleural effusions - pollution and cancer
Session: Mesothelioma and malignant pleural effusions - pollution and cancer
Session type: Thematic Poster Session
Number: 3278
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Cvitanovic, Z. Ivancevic (Split, Croatia). Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study. Eur Respir J 2004; 24: Suppl. 48, 3278

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rise in rates of mesothelioma, asbestosis and of benign asbestos-related pleural disease in NSW over the last 15 years
Source: Eur Respir J 2006; 28: Suppl. 50, 694s
Year: 2006

Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007


Non-malignant pleural disease from asbestos and malignant pleural mesothelioma
Source: Eur Respir Monogr 2020; 89: 141-149
Year: 2020


Survival of patients with malignant pleural effusions: a three-year prospective self-experience study
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Lung function in patients with benign asbestos related pleural disease
Source: Eur Respir J 2003; 22: Suppl. 45, 185s
Year: 2003

Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020

Malignant pericardial effusion in lung cancer patients
Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Year: 2006

Tumours of the pleura - Mesothelioma
Source: Respipedia Article
Year: 2017

The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Source: Eur Respir Rev 2016; 25: 472-486
Year: 2016



Malignant pleural disease
Source: Annual Congress 2012 - PG16 ERS/ACCP joint course on diagnostic and management strategies for pleural disorders
Year: 2012



Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010

Malignant pleural mesothelioma: CT findings in 49 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 271s
Year: 2002

Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Epidemiology, etiology, prognosis and presentation of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020


Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results
Source: Eur Respir J 2005; 26: 989-992
Year: 2005



Malignant pleural mesothelioma:a 16-year, single centre experience
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017